AI-Mind is set to hold its 6th General Assembly (GA) in Zurich, Switzerland on March 16-17, 2023. With over 60 participants joining in person, the upcoming GA will be an excellent opportunity to discuss project progress and highlight the closure of the second year of AI-Mind . Additionally, the #AIMindGA coincides with Brain Awareness Week, the global campaign to increase public awareness of the progress and benefits of brain research. As part of our commitment to this cause, we encourage all GA attendees and the public to use the hashtags #BrainWeek and #BrainAwarenessWeek in their social media posts to help raise awareness about the importance of brain research. 

The GA’s agenda features a diverse range of presentations, panel discussions and lectures from external guests. This year’s assembly will primarily focus on machine and deep learning, algorithms, platform architecture, user trust and other technical aspects that are essential for developing AI-based tools.

The first day of the assembly will begin with an opening speech by Jeanette Müller (accelCH), followed by presentations on project progress by Ira Haraldsen (OUS) and technical coordination by Ainar Drews (UiO/USIT). Next, the program will feature two informative lectures, one by an external guest and the other by a project partner. In the first lecture, Stéphane Epelbaum, a representative from Eli Lilly, will talk about Eli Lilly’s neurodegeneration portfolio. This will be followed by a presentation by Tita Alissa Bach (DNV), who will discuss the crucial topic of building user trust in AI-enabled systems. Additionally, the progress of WP3, which involves AI-modelling of the AI-Mind Connector & Predictor, and WP2 – Data Management and Feature Extraction will be discussed by project partners. Furthermore, a series of presentations will be given on WP4 – Data Analysis and Interactive Visualization Platform.

The second day of the event will begin with a short introduction, followed by presentations on communication and dissemination of the project’s findings and clinical implementation of the AI-Mind Connector & Predictor in the clinical setting. To ensure the efficient exchange of information and boost collaboration between partners coming from across Europe, sessions dedicated to different WPs will take place throughout the afternoon of the second day. Task groups within WP1 – Concept Governance and Requirements, WP6 – Health Technology Assessment and WP8 – Project Management will discuss the next steps and challenges that they are facing.